The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.EBI
The University of Texas At Austin
Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors.EBI
The University of Texas At Austin
Synthesis and biological evaluation of p38alpha kinase-targeting dialkynylimidazoles.EBI
The University of Texas At Austin
Targeting σEBI
The University of Texas At Austin
NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth.EBI
The University of Texas At Austin
Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.EBI
The University of Texas At Austin
Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth.EBI
The University of Texas At Austin